Dr. Agarwal’s Health Care Ltd (AHCL) announced that its Scheme of Amalgamation with Dr. Agarwal’s Eye Hospital Ltd (AEHL) has become effective and operative from November 1.
The development follows an order dated September 30, 2026, issued by the National Company Law Tribunal (NCLT), Chennai Bench, which sanctioned the Scheme. After completing the necessary legal and procedural formalities, the amalgamation officially took effect, according to the company.
The consolidation brings the two listed entities together within Dr. Agarwal’s Health Care Ltd. According to the company, the move simplifies the group's corporate structure as it continues to expand its eye-care network. The combined structure is intended to provide a more unified framework for governance, capital allocation, and long-term business planning.
The board has fixed Wednesday, November 18, 2026, as the record date. This date will determine the eligible shareholders of Dr. Agarwal’s Eye Hospital Ltd who will receive shares of Dr. Agarwal’s Health Care Ltd under the approved Scheme.
Under the approved share exchange ratio, eligible AEHL shareholders will receive 23 fully paid-up equity shares of AHCL, having a face value of ₹1 each, for every 2 fully paid-up equity shares of AEHL with a face value of ₹10 each. This translates to 11.5 AHCL shares for every single AEHL share held.
The company stated that the consolidation will help support closer alignment across investments in hospitals, clinical capabilities, technology, and talent. Additionally, it aims to provide shareholders and investors with a clearer view of the combined organization.
Commenting on the development, Adil Agarwal, Chief Executive Officer of Dr. Agarwal’s Health Care Ltd, said, "Our focus remains on creating long-term value through disciplined expansion, stronger operating performance and continued investment in clinical excellence. We believe the combined structure will support greater organisational alignment as we scale across markets."
"Corporate restructurings and amalgamations of listed entities play a crucial role in streamlining operations and simplifying governance frameworks. By consolidating entities under one unified structure, organizations can achieve better capital allocation, clearer financial visibility for investors, and improved alignment across clinical and technological investments. This move highlights the strategic importance of structural consolidation for healthcare providers looking to scale efficiently and manage multi-market operations with greater transparency." — Dr. Shishir Gupta, Founder & CEO, StartupLanes
Recent StartupLanes Articles
Browse through our 30 latest publications on venture capital, startups, and angel investing.